United States· US:0168-0258_04a61040-37c4-4229-a1f9-8bd34c720e14
Clotrimazole and Betamethasone Dipropionate
A medicinal product containing clotrimazole; betamethasone dipropionate, registered in United States by E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CLOTRIMAZOLE; BETAMETHASONE DIPROPIONATE
- Manufacturer
- E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110168-0258-15
- ndc110168-0258-46
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clotrimazole; betamethasone dipropionate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLotriderm creamOrganon Pharma (UK) Ltd
- CanadaLOTRIDERMORGANON CANADA INC.
- GermanyLotricomb CremeOrganonhealthcare Gmbh
- SpainBETA-MICOTER 10 MG/G + 0,5 MG/G CREMATeofarma S.R.L.
- PolandLotridermOrganon Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Lotriderm
- Germany · Lotricomb Creme, Lotricomb Salbe
- Spain · Beta-Micoter
- United Kingdom (Northern Ireland) · Lotriderm
- Luxembourg · Lotriderm
- Poland · Lotriderm
- Portugal · Flotiran
- Romania · Clo-Ekarzin
- Slovenia · Lotriderm
- Slovakia · Lotriderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4682001-62f9-43bc-935b-6bdac3f834bb GET /v1/drugs/e4682001-62f9-43bc-935b-6bdac3f834bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10; .5",
"substance": "CLOTRIMAZOLE; BETAMETHASONE DIPROPIONATE",
"productndc": "0168-0258",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g",
"application_number": "ANDA075502",
"marketing_category": "ANDA"
}See everything about clotrimazole; betamethasone dipropionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.